Safety Study of IMP761 Immunosuppressive Antibody

We are testing the safety of a new immunosuppressive antibody in healthy volunteers. This study aims to understand how the antibody affects the body before further testing in patients.

1-2 yearsSafety phase (I)Infectious Diseases

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre for Human Drug Research
Immunology
Oegstgeest, Netherlands
Sponsor: Immutep
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.